Six Questions For Janssen Pharma Chairman Paul Stoffels
This article was originally published in PharmAsia News
Executive Summary
Amid increasing competition, the need is to be the best in collaboration with academics, and not to rely on a single regulatory agency amid regulatory delays in China, stresses Johnson & Johnson senior executive Paul Stoffels in a wide-ranging exclusive interview with PharmAsia News.